For each subject , 1 mg ( 2 mg/mL ) of tacrolimus solution in polyethylene glycol 400 was administered to each location in the gastrointestinal tract via a site-specific radiolabeled delivery capsule , which can release tacrolimus solution at specific sites of the gastrointestinal tract .